April 02, 2021
Article
If approved, daridorexant would become the first sleep medication to demonstrate an improvement in sleep and daytime functioning.
March 08, 2021
The FDA will consider the approval of the biologics license application next month.
Students share their experience in the virtual classroom, navigating new requirements, and the lessons learned from their position in a global pandemic.
March 04, 2021
Genetically-indexed inhibition of TNF-TNFR1 signaling was predicted to reduce the risk of Crohn’s disease and ulcerative colitis, and increased the risk of multiple sclerosis.